Inhibition of Tumor Growth and Metastasis by Targeting Tumor-Associated Angiogenesis with Antagonists to the Receptors of Vascular Endothelial Growth Factor Zhenping ZhuLarry Witte OriginalPaper Pages: 195 - 212
Tyrosine Kinase Inhibitors in Preclinical Development Mark L. LevittPatrick P. Koty OriginalPaper Pages: 213 - 226
Protein Kinase C Targeting in Antineoplastic Treatment Strategies W. David JarvisSteven Grant OriginalPaper Pages: 227 - 240
Farnesyl Protein Transferase Inhibitors and Other Therapies Targeting the Ras Signal Transduction Pathway David W. End OriginalPaper Pages: 241 - 258
Epidermal Growth Factor Receptor Inhibition in Cancer Therapy: Biology, Rationale and Preliminary Clinical Results Shyh-Min HuangPaul M. Harari OriginalPaper Pages: 259 - 269
Flavopiridol: the First Cyclin-Dependent Kinase Inhibitor in Human Clinical Trials Adrian M. Senderowicz OriginalPaper Pages: 313 - 320